Ann Hake is a Neurologist with fellowship training in neurodegenerative diseases and postgraduate training in medical informatics. She currently is the physician member of the multidisciplinary Digital Health Research and Development group, which seeks to investigate, validate, and enable usage of digital applications and sensors in clinical trials and practice. Dr. Hake also serves as the Vice Chair of Lilly’s Bioethics Advisory Committee. Previously at Eli Lilly she has led late- and early-phase clinical trials and has provided medical leadership in Medical Affairs in neurodegeneration and in migraine. Prior to joining Lilly, she was an Associate Professor of Clinical Neurology at Indiana University; she continues to hold a volunteer faculty position and sees Neurology outpatients twice monthly, and serves on the Institutional Review Board.